A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes Mellitus

PHASE2CompletedINTERVENTIONAL
Enrollment

292

Participants

Timeline

Start Date

May 12, 2015

Primary Completion Date

June 3, 2016

Study Completion Date

June 3, 2016

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Bexagliflozin tablets

Bexagliflozin tablets are blue caplet-shaped, film-coated tablets that are intended for use in investigational studies in humans.

DRUG

Bexagliflozin tablets, placebo

Bexagliflozin tablets, placebo, are blue caplet-shaped, film-coated tablets that are intended for use in investigational studies in humans.

Trial Locations (50)

13760

Regional Clinical Research, Inc, Endwell

19446

Detweiler Family Medicine and Associate, P.C., Lansdale

28144

PMG Research of Salisbury, Salisbury

28467

Calabash Medical Center, Calabash

28557

Diabetes & Endocrinology Consultants PC, Morehead City

29582

North Myrtle Beach Family Practice, Myrtle Beach

30338

PICR Clinic, Atlanta

32127

Progressive Medical Research, Port Orange

32806

Compass Research LLC, Orlando

33012

AGA Clinical Trials, Hialeah

33016

Sweet Hope Research Specialty, Inc, Miami Lakes

33054

Sunshine Research Center, Opa-locka

33316

M&O Clinical Research LLC, Fort Lauderdale

34748

Compass Research North, Leesburg

44224

Summit Research Group, LLC, Stow

45255

CTI Research, Cincinnati

63141

Sundance Clinical Research, St Louis

75115

Global Medical Research, DeSoto

76164

Rockwood Medical Clinic, Fort Worth

84107

Wasatch Clinical Research, Salt Lake City

85381

Phoenix Medical Research Institute LLC, Peoria

85712

Advanced Arizona Clinical Research, Tucson

90255

National Research Institute, Huntington Park

90806

Long Beach Clinical Trials, Long Beach

91303

Hope Clinical Research, LLC, Canoga Park

91307

Infosphere Clinical Research, Inc, West Hills

91710

Catalina Research Institute, Chino

91950

Synergy San Diego, National City

92103

Artemis Institute for Clinical Research, LLC, San Diego

95821

Northern California Research, Sacramento

97239

Columbia Research Group, Inc., Portland

08611

Premier Research Ltd, Trenton

231-0023

Medical Corporation Hitomi-kai Motomachi Takatsuka Naika Clinic, Yokohama Naka-ku

615-8125

Medical Corporation Hayashi katagihara Clinic, Nishikyo-ku

615-0035

Medical Corporation KEISEIKAI Kajiyama clinic, Ukyou-ku

536-0008

Ikeoka Medical Corp. Ikeoka Clinic, Joto-ku

569-1123

Miyauchi Medical Center, Takatsuki-shi

560-0082

Medical Corporation Senrichuo Ekimae Clinic, Toyonaka-shi

355-0328

Medical Corporation Segawa Hospital, Hikigun Ogawamachi

350-0851

Medical Corporation Yukeikai Asano Clinic, Kawagoe-shi

333-0844

Medical Corporation Ishii Internal Medicine Clinic, Kawaguchi

336-0963

Medical Corporation Fusanokai Shimizu Clinic Fusa, Saitama-shi

192-0046

Medical Corp. SEIKOUKAI New Medical Research System Clinic, Hachioji-shi

124-0024

Medical Corporation Jototowakai Shinkoiwa ekimae sogo Clinic, Katsushika-ku

105-7390

Medical Corporation IHL Pedi Shiodome Medical Clinic, Minato-ku

108-0075

Medical Corporation IHL Shinagawa East One Medical Clinic, Minato-ku

143-0015

Kenkokan Suzuki Clinic, Ōta-ku

150-0002

Medical Corporation Souyu-kai Hirahata Clinic, Shibuya-ku

141-0032

Medical Corporation Yuhokai Miho-Clinic, Shinagawa-ku

171-0021

Ikebukuro Metropolitan Clinic, Toshima-ku

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Theracos

INDUSTRY